Format

Send to

Choose Destination
Arch Cardiovasc Dis. 2014 Nov;107(11):615-24. doi: 10.1016/j.acvd.2014.07.052. Epub 2014 Oct 16.

Percutaneous pulmonary valve endocarditis: incidence, prevention and management.

Author information

1
Centre de référence malformations cardiaques congénitales complexes-M3C, Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris, Paediatric Cardiology, Paris, France.
2
Centre de référence malformations cardiaques congénitales complexes-M3C, Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris, Paediatric Cardiology, Paris, France; Centre de référence malformations cardiaques congénitales complexes-M3C, George Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris, Unit for Adults with Congenital Heart Defects, Paris, France. Electronic address: younes.boudjemline@nck.aphp.fr.

Abstract

The epidemiology of infective endocarditis is changing rapidly due to the emergence of resistant microorganisms, the indiscriminate use of antibiotics, and an increase in the implantation of cardiovascular devices including percutaneous valves. Percutaneous pulmonary valve implantation has achieved standard of care for the management of certain patients with right ventricular outflow tract dysfunction. With its expanding use, several cases of early and delayed infective endocarditis with higher morbidity and mortality rates have been reported. This review summarizes the trends in percutaneous pulmonary valve infective endocarditis, postulates proposed mechanisms, and elaborates on the prevention and management of this unique and potentially fatal complication.

KEYWORDS:

Cardiopathies congénitales; Congenital heart disease; Endocardite infectieuse; Infective endocarditis; Melody valve; Transcatheter pulmonary valve; Valve Melody; Valve pulmonaire percutanée

PMID:
25445753
DOI:
10.1016/j.acvd.2014.07.052
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center